Dr. Murphy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
420 Delaware St Se
Mmc 284
Minneapolis, MN 55455Phone+1 612-626-5031
Education & Training
University of MinnesotaFellowship, Nephrology, 2018 - 2020- University of MinnesotaResidency, Internal Medicine, 2015 - 2018
University of California San Francisco School of MedicineClass of 2015
Certifications & Licensure
MN State Medical License 2020 - 2025
WI State Medical License 2016 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- SGLT2 Inhibitors After Acute Kidney Injury With Indications Pilot Start of enrollment: 2024 Apr 01
Roles: Contact
Publications & Presentations
PubMed
- A cohort study of sodium-glucose cotransporter-2 inhibitors after acute kidney injury among Veterans with diabetic kidney disease.Daniel P Murphy, Julian Wolfson, Scott Reule, Kirsten L Johansen, Areef Ishani
Kidney International. 2024-07-01 - NephroConnect: Patterns, Preferences, Barriers, and Potentials in the Global Nephrology Community's Social Media Landscape.Sibel G Bek, Sabine Karam, Daniel P Murphy, José A Moura-Neto, Sibel Balcı
Kidney International Reports. 2024-06-01 - 1 citationsKidney Outcomes with Sodium-Glucose Cotransporter-2 Inhibitor Initiation after AKI among Veterans with Diabetic Kidney Disease.Daniel P Murphy, Julian Wolfson, Scott Reule, Kirsten L Johansen, Areef Ishani
Kidney360. 2024-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
